Neurological

Neurologic conditions include problems such as strokes, head injuries, Parkinson's, and multiple sclerosis.

Fast Track has special programs for these conditions. We are a clinic that has a significant amount of experience treating these types of problems. In addition to having experienced therapists, we make sure that our therapists have the proper amount of time to treat these conditions. Patients will receive up to one hour of care, one-on-one, with a licensed physical therapist. When treating neurologic conditions there are no shortcuts for producing exceptional results. One-on-one treatment with a physical therapist cannot be substituted with unqualified staff or machines. At Fast Track, we provide superior care so that you can have the outcomes you deserve.

  • Research, Parkinson's: Although medication therapy is generally effective in the clinical management of Parkinson's disease, additional improvement of some gross motor symptoms may be achieved through the use of nonpharmalogical treatments such as physical therapy and exercise rehabilitation. (Geriatrics and Aging, 2007)
  • Research, Multiple Sclerosis: Favorable fatigue, depression and quality-of-life scores were reported by persons of multiple sclerosis who regularly participated in physical activity when compared to persons with multiple sclerosis who were classified as non-exercisers. (Health Quality Life Outcomes, 2009)
  • Research, Multiple Sclerosis: Moderate resistance training programs can improve muscle function without injuries and can be a promising therapy to delay the functional deterioration in multiple sclerosis patients. (Int Journal Sports Med, 2009)
  • Research, Stroke: Virtual reality has an augmented effect on balance and associated locomotor recovery in adults with hemiparetic stroke when added to conventional therapy. (American Journal Physical Medicine and Rehabilitation, 2009) Fast Track is the only therapy facility in town with virtual reality.
  • Click here for research on multiple sclerosis
  • Click here for research on Parkinson's Disease